Results

Total Results: 503 records

Showing results for "breast".
Users also searched for: breast cancer

  1. Politi (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
    December 26, 2012 - Preference-­‐Sensitive Decisions: • BCS vs. mastectomy for average risk patients with early stage breast … • Recommends against breast self-­‐exam (BSE).
  2. effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
    November 12, 2019 - What is the available evidence concerning levels in maternal serum/blood, fetal/infant serum/blood, breast … Reduced breast milk production. Symptoms related to withdrawal of medication. … adverse events: Breastfeeding – delayed initiation, cessation, reduced frequency, reduced volume of breast … Reduced breast milk production. Symptoms related to withdrawal of medication. … Appendix A: Literature Search Search 1 – headache treatment PubMed (“Breast Feeding”[Mesh] OR “
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
    March 23, 2019 - What is the available evidence concerning levels in maternal serum/blood, fetal/infant serum/blood, breast … gain, tachycardia, hypertension, gastrointestinal) • Preterm labor, cesarean section • Reduced breast … gain, tachycardia, hypertension, gastrointestinal) • Preterm labor, cesarean section • Reduced breast … analog” OR octreotide) AND (Pharmacokinetic* OR pharmacodynamic* OR "Pharmacokinetics"[Mesh] OR “Breast … OR #18 OR #19 #19: 'amnion fluid'/de #18: 'umbilical cord blood'/de #17: 'fetus blood'/de #16: 'breast
  4. effectivehealthcare.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
    March 13, 2012 - In 2012, it is expected to be the fourth most commonly diagnosed cancer (after prostate, breast, and … cancer and aid in determination of prognosis in breast cancer.” 5 Using GEP tests could improve the … Given the current role of GEP testing in patients with breast cancer, questions formulated in a report … for the Agency for Healthcare Research and Quality (AHRQ) on GEP testing in patients with breast cancer … Impact of Gene Expresion Profiling Tests on Breast Cancer Outcomes.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
    June 01, 2012 - For example, the Oncotype Dx® test evaluates the tumor genome of excised tumors from patients with breast … BRCA1 and BRCA2 mutations can influence the risk for multiple cancer types including breast, ovarian, … Similarly, BRCA1 and BRCA2 mutations can increase the risk of a number of cancer types including breast … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors. … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors.
  6. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
    June 01, 2012 - For example, the Oncotype Dx® test evaluates the tumor genome of excised tumors from patients with breast … BRCA1 and BRCA2 mutations can influence the risk for multiple cancer types including breast, ovarian, … Similarly, BRCA1 and BRCA2 mutations can increase the risk of a number of cancer types including breast … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors. … HER2 Testing To Manage Patients With Breast Cancer or Other Solid Tumors.
  7. effectivehealthcare.ahrq.gov/health-topics/mastectomy/
  8. effectivehealthcare.ahrq.gov/health-topics/medicare-0
    December 08, 2017 - Points #13: Use of preoperative MRI among older women with ductal carcinoma in situ and locally invasive breast
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
    September 13, 2013 - events o Cancer (incident or mortality)  Total cancer  Prostate cancer  Colorectal cancer  Breast … outcomes  Cancer intermediate outcomes (colorectal adenoma, aberrant crypt cells, and mammographic breast … Arrow 1 Arrow 2 Arrow 2 Arrow 3 Arrow 4 Arrow 5 Arrow 5 Arrow 6 Arrow 6 Immune outcomes Breast … • Cancer intermediate outcomes, including colorectal adenoma aberrant crypt foci and mammographic breast … density (quantitative whole-breast density) • Immune function clinical outcomes (infectious diseases
  10. Appendices (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-clinician-level-strategies-appendixes-draft-tech-brief.pdf
    February 01, 2023 - Expressive writing intervention for posttraumatic stress disorder among Chinese American breast cancer … Catalyzing Navigation for Breast Cancer Survivorship (CaNBCS) in Safety- Net Settings: A Mixed Methods … The association of stressful life events on weight loss efforts among African American breast cancer … Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence … Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors.
  11. effectivehealthcare.ahrq.gov/products/uterine-fibroids/research-protocol
    February 29, 2016 - (EMD Serono, Inc.), Rockland, MA, USA Goserelin Acetate, Zoladex® FDA-labeled indications : Breast … combination with flutamide for locally confined stage B2-C disease Non-FDA labeled indications : Breast … central precocious puberty; endometriosis; advance prostate cancer Non-FDA labeled indications : Breast … cancer, following disease progression while on an aromatase inhibitor; neoadjuvant therapy in breast … cancer in premenopausal women with breast cancer; endometriosis, dysfunctional uterine bleeding; uterine
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
    March 01, 2016 - Rockland,  MA     USA   Goserelin  Acetate     Zoladex®   FDA-­labeled  indications:  Breast  cancer …   flutamide  for  locally  confined  stage  B2-­C   disease     Non-­FDA  labeled  indications:   Breast … following  disease  progression  while  on   an  aromatase   inhibitor;;  neoadjuvant  therapy  in  breast …  cancer  in   premenopausal  women  with  breast  cancer;;   endometriosis,  dysfunctional  uterine   … Wilmington,  DE     USA   Raloxifene   Hydrochloride     Evista®   FDA-­labeled  indications:     Breast
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
    May 01, 2015 - pain, poor milk supply, maternal breast engorgement, and refusing the breast.2 Ineffective latch is … We sought information on outcomes related to breast- and bottle-feeding and related to tongue-tie in … Bottle feedings to supplement breast feeding decreased over time in the case series. … Immediate nipple pain relief after frenotomy in breast-fed infants with ankyloglossia: a randomized … Tongue tie division in infants with breast feeding difficulties.
  14. effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
    June 10, 2013 - cardiovascular events Cancer (incident or mortality) Total cancer Prostate cancer Colorectal cancer Breast … outcomes Cancer intermediate outcomes (colorectal adenoma, aberrant crypt cells, and mammographic breast … outcomes]) Cancer (incidence or mortality) clinical outcomes, including prostate, colorectal cancer, breast … Cancer intermediate outcomes, including colorectal adenoma aberrant crypt foci and mammographic breast … density (quantitative whole-breast density) Immune function clinical outcomes (infectious diseases
  15. Menopause Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
    March 01, 2015 - , stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; or endometrial, breast … stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; or endometrial, breast … Trials enrolling women with preexisting conditions (e.g., heart disease, lupus, fibromyalgia, breast … We did not include studies examining effects among breast cancer survivors—women frequently affected … Placebo Strength of Evidence Breast cancer — Vitamin E High Breast cancer SSRI Insufficient Colorectal
  16. effectivehealthcare.ahrq.gov/products?f%5B0%5D=field_product_type%3Aresearch_report&f%5B1%5D=field_product_type%3Asystematic_review&f%5B2%5D=field_product_type%3Atechnical_brief&sort_by=field_product_pub_date
    September 20, 2021 - of a Machine Learning and Text Mining Tool Research Report August 10, 2021 Breast
  17. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
    August 27, 2012 -  = +0.84 RTI International Research Triangle Institute Maximum Acceptable Breast-Cancer Risk … RTI International Research Triangle Institute Maximum Acceptable Breast-Cancer Risk Vasomotor Symptoms
  18. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cf_intro_ehc_cf_overview_1012.pdf
    October 13, 2011 - and Consumer Involvement Technical Expert Panel (TEP) Members Affiliation Amy Bonoff National Breast
  19. effectivehealthcare.ahrq.gov/sites/default/files/lavallee-text.pdf
    October 13, 2011 - Patient and Consumer Involvement Technical Expert Panel (TEP) Members Affiliation Amy Bonoff National Breast
  20. effectivehealthcare.ahrq.gov/sites/default/files/fagerlin-presentation.pdf
    November 11, 2015 - Additionally, in  work that I’ve done, people will say, for example, with  breast cancer, that the … If I could   tell you   that a drug could   reduce your risk of breast cancer or prostate cancer … S o if you  have breast cancer, your doctor will often  go to this Web site and give you information … people were really upset about them, because we all have stories of friends who got diagnosed  with  breast

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: